Algert Global’s Zomedica Corp. ZOM Stock Holding History

Algert Global’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-131,248	Closed	-$44K	–	1457
2022 Q1	$44K	Buy	+131,248	New	+$42.9K	﹤0.01%	1146

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Algert Global's ZOM Position: Q2 2022 in Review

Algert Global sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 131,248 shares — an estimated $44K sold.

Algert Global first reported a position in ZOM in Q1 2022 and held it in 1 quarter. The position peaked at $44K in Q1 2022. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

Algert Global reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
Algert Global sold 131,248 Zomedica Corp. shares in Q2 2022, an estimated $44K.
Algert Global first reported a position in Zomedica Corp. in Q1 2022 and held it in 1 quarter.
Algert Global's Zomedica Corp. position peaked at $44K in Q1 2022.
97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.